EBM Stock Overview
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Eastwood Bio-Medical Canada Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.54 |
| 52 Week High | CA$1.15 |
| 52 Week Low | CA$0.28 |
| Beta | -0.058 |
| 1 Month Change | -32.50% |
| 3 Month Change | -35.71% |
| 1 Year Change | n/a |
| 3 Year Change | -61.43% |
| 5 Year Change | -76.52% |
| Change since IPO | 35.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EBM | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | n/a | 31.5% | 15.9% |
Return vs Industry: Insufficient data to determine how EBM performed against the Canadian Healthcare industry.
Return vs Market: Insufficient data to determine how EBM performed against the Canadian Market.
Price Volatility
| EBM volatility | |
|---|---|
| EBM Average Weekly Movement | 47.3% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.3% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: EBM's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine EBM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Youngsoo Kim | www.eleotin.ca |
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company’s licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism.
Eastwood Bio-Medical Canada Inc. Fundamentals Summary
| EBM fundamental statistics | |
|---|---|
| Market cap | CA$37.20m |
| Earnings (TTM) | -CA$484.16k |
| Revenue (TTM) | CA$653.54k |
56.9x
P/S Ratio-76.8x
P/E RatioIs EBM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBM income statement (TTM) | |
|---|---|
| Revenue | CA$653.54k |
| Cost of Revenue | CA$246.50k |
| Gross Profit | CA$407.05k |
| Other Expenses | CA$891.21k |
| Earnings | -CA$484.16k |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.007 |
| Gross Margin | 62.28% |
| Net Profit Margin | -74.08% |
| Debt/Equity Ratio | -5.7% |
How did EBM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 12:09 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/07/31 |
| Annual Earnings | 2023/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eastwood Bio-Medical Canada Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|